These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27461566)

  • 1. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
    Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
    J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo].
    Krasikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
    Mol Biol (Mosk); 2015; 49(6):1007-15. PubMed ID: 26710783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.
    Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M
    Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
    Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
    J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
    Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
    Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence.
    Taheri M; Tehrani HA; Farzad SA; Korourian A; Arefian E; Ramezani M
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113048. PubMed ID: 39236459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
    Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
    J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.
    Kucerova L; Poturnajova M; Tyciakova S; Matuskova M
    Stem Cell Res; 2012 Mar; 8(2):247-58. PubMed ID: 22265744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
    NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
    J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
    Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
    Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.
    Nouri FS; Wang X; Hatefi A
    J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
    Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
    Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.
    Zaoui K; Bossow S; Grossardt C; Leber MF; Springfeld C; Plinkert PK; Kalle Cv; Ungerechts G
    Cancer Gene Ther; 2012 Mar; 19(3):181-91. PubMed ID: 22076043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
    Altanerova U; Jakubechova J; Benejova K; Priscakova P; Pesta M; Pitule P; Topolcan O; Kausitz J; Zduriencikova M; Repiska V; Altaner C
    Int J Cancer; 2019 Feb; 144(4):897-908. PubMed ID: 30098225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
    Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
    Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy.
    Leveille S; Samuel S; Goulet ML; Hiscott J
    Cancer Gene Ther; 2011 Jun; 18(6):435-43. PubMed ID: 21394109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
    Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.